BioSyent Releases Financial Results for Q3 and YTD 2025
Provided By GlobeNewswire
Last update: Nov 20, 2025
MISSISSAUGA, Ontario, Nov. 20, 2025 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today its financial results for the three months (Q3) and nine months (YTD) ended September 30, 2025. Key highlights include:
Read more at globenewswire.com
